Welcome to our dedicated page for Transcat news (Ticker: TRNS), a resource for investors and traders seeking the latest updates and insights on Transcat stock.
Overview of Transcat Inc
Transcat Inc is a distinguished provider of accredited calibration, repair, inspection, and compliance services, integrating advanced laboratory instrument services with a robust distribution arm. Key industry-specific terms such as calibration, laboratory instrument services, and ISO accreditation are pivotal in illustrating its deep-rooted technical expertise. The company operates through two primary segments: the Service segment which focuses on calibration and validation services, and the Distribution segment which supplies professional-grade test, measurement, and control instrumentation.
Core Services and Capabilities
The Service segment of Transcat Inc is engineered to offer comprehensive solutions in the realms of analytical instrument qualifications, equipment validation, and process inspection. Emphasizing precision, the firm addresses an extensive range of measurement parameters through its adherence to ISO/IEC 17025 accreditation standards. This rigorous quality framework reinforces the reliability of its services across various compliance-heavy industries such as medical devices, life science, biotechnology, and pharmaceuticals.
Industry Applications and Market Position
Transcat Inc has strategically positioned itself within several regulated and manufacturing intensive industries. Its service portfolio is tailored to meet the stringent needs of FDA-regulated sectors including pharmaceutical and medical device industries, as well as industrial manufacturing, energy, utilities, and chemical processing. This multi-industry focus not only diversifies its revenue streams but also reinforces its reputation as a dependable and versatile service provider.
Distribution Segment and Product Offerings
Alongside its services, Transcat Inc operates a well-integrated Distribution segment. This division specializes in marketing and distributing a broad range of professional-grade handheld test, measurement, and control instruments. By collaborating with renowned brand names, the company ensures that customers have access to premier and proprietary product lines, which complement the precision and reliability of its calibration services.
Operational Excellence and Quality Assurance
With over 20 strategically located centers of excellence across the United States, Canada, and Puerto Rico, Transcat Inc demonstrates a commitment to operational efficiency and quality. The company leverages its widespread network to ensure prompt turnaround times and accurate service delivery. The stringent application of internationally recognized standards underpins its operational protocols, providing a consistent and transparent framework that enhances both customer confidence and compliance adherence.
Competitive Differentiation and Strategic Value
Transcat Inc differentiates itself through its dual-operating model which combines an extensive service portfolio with a dedicated distribution network. This integration allows the firm to serve as a single-source partner for industries that demand both precision in calibration and high-quality instrumentation. Its ability to maintain accreditation across diverse measurement parameters and a robust geographic footprint underlines its strategic importance in regulated markets.
Conclusion
In summary, Transcat Inc stands out by delivering a comprehensive suite of services and products that assure quality, compliance, and operational precision. Its commitment to rigorous accreditation standards and extensive industry expertise cements its role as a critical resource for organizations in regulated and industrial sectors. The company’s balanced focus on both calibration services and the distribution of high-quality test instruments positions it as a trusted entity within its competitive landscape.
Transcat (NASDAQ: TRNS) reported its Q3 FY2025 financial results with consolidated revenue growing 2.4% to $66.8 million. The company experienced mixed performance across segments, with Distribution revenue increasing 6.5% to $25.2 million while Service revenue remained flat at $41.6 million.
Notable financial metrics include a decrease in gross profit by 6% to $19.7 million, with gross margin declining 260 basis points. Operating income dropped 51.1% to $2.1 million, and net income decreased 29.6% to $2.357 million. Adjusted EBITDA fell 13.2% to $7.9 million.
The company completed the acquisition of Martin Calibration, a significant addition with revenue exceeding $25 million. Service organic revenue was impacted by holiday timing, showing a 3.8% decrease. Management expects FY25 Service organic revenue growth in the mid-to-low single digits and anticipates a return to historical organic growth levels.
Transcat (Nasdaq: TRNS) has scheduled its third quarter fiscal year 2025 earnings release and conference call. The company will announce its financial results after market close on Monday, January 27, 2025. A conference call and webcast to discuss the results and corporate strategy will be held on Tuesday, January 28, 2025, at 11:00 a.m. Eastern Time.
The conference call can be accessed via phone at (201) 689-8471, and a webcast with accompanying slides will be available on Transcat's investor relations website. A replay will be accessible until February 4, 2025, by dialing (412) 317-6671 with conference ID 13750934, or through the company's website where a transcript will also be posted.
Transcat (Nasdaq: TRNS) has acquired Martin Calibration Inc. for $79 million, comprising $69 million in cash and $10 million in company stock. Martin, an ISO-17025 Accredited calibration laboratory network with over $25 million in revenue, operates seven labs across the Midwest, including its flagship Minneapolis facility and locations in Chicago, Milwaukee, Eau Claire, Tempe, and Los Angeles.
The acquisition, Transcat's largest to date, strengthens its presence in the Medical, Life Science, Aerospace, and Nuclear sectors. Martin brings nearly 150 employees and 35 years of metrology expertise to Transcat's operations. The strategic move expands Transcat's geographic reach, particularly in the medical device and life science-rich Minneapolis region, while adding new capabilities and expertise to its service portfolio.
Transcat (NASDAQ: TRNS) reported Q2 fiscal 2025 results with consolidated revenue up 8% to $67.8 million. Service Revenue grew 6% to $44.1 million, marking the 62nd consecutive quarter of growth, while Distribution Revenue increased 11.1% to $23.7 million. Net income rose significantly to $3.3 million ($0.35 per diluted share) from $460,000 ($0.06 per diluted share) in the prior year. The company faced challenges with its Nexa business slowdown and hurricane impacts on Becnel operations, leading to a slight decline in gross margins. Management expects mid-single-digit organic Service revenue growth for FY25 and anticipates returning to high single-digit growth by first half of FY26.
Transcat, Inc. (Nasdaq: TRNS), a leading provider of accredited calibration services and professional grade test instrumentation, has announced the release of its second quarter fiscal year 2025 results. The company will disclose these results after the financial markets close on Monday, October 28, 2024.
Following the release, Transcat will host a conference call and webcast on Tuesday, October 29, 2024, at 11:00 a.m. Eastern Time. During this event, the company will review its financial and operating results, discuss corporate strategy and outlook, and conduct a question-and-answer session.
Interested parties can access the call via phone at (201) 689-8471 or through a webcast with an accompanying slide presentation available on Transcat's investor relations website. A telephonic replay will be accessible until November 5, 2024, by dialing (412) 317-6671 and entering conference ID 13749365.
Transcat Inc. (Nasdaq: TRNS) reported strong Q1 fiscal 2025 results, with significant gross margin expansion and EBITDA growth. Key highlights include:
- Consolidated revenue up 10.1% to $66.7 million
- Gross profit increased 21.1% to $22.7 million
- Gross margin expanded 310 basis points to 34.0%
- Adjusted EBITDA grew 20.4% to $10.2 million
- Adjusted diluted EPS rose 30.8% to $0.68
The Service segment saw 9.8% revenue growth and 150 basis points margin expansion. The Distribution segment experienced 10.5% sales growth and 620 basis points margin improvement. Transcat expects high single-digit to low double-digit organic Service revenue growth for fiscal 2025.
Transcat, Inc. (Nasdaq: TRNS), a leading provider of accredited calibration services and professional test equipment, has announced its upcoming first quarter fiscal year 2025 conference call and webcast. The company will release its financial results on Monday, July 29, 2024, after market close. The conference call is scheduled for Tuesday, July 30, 2024, at 11:00 a.m. Eastern Time.
Investors and analysts can join the call via phone at (201) 689-8471 or access the webcast and accompanying slide presentation on Transcat's investor relations website. A replay of the call will be available until August 6, 2024, by dialing (412) 317-6671 with conference ID 13747789. The webcast replay and transcript will also be accessible on the company's website.
Transcat reported significant growth in fiscal 2024, with double-digit organic service revenue growth and gross margin expansion. Fourth-quarter service gross margin expanded by 170 basis points due to a 13% increase in organic service growth. Distribution gross margin rose by 510 basis points, driven by rental strength. Consolidated adjusted EBITDA grew 29.8%, with a 200 basis point margin expansion.
Fiscal 2024 saw a 14.3% increase in consolidated revenue to $70.9 million. Consolidated gross profit rose by 25.5% to $24.0 million. Net income nearly doubled to $6.9 million, while adjusted EBITDA increased by 29.8% to $11.7 million. The company completed three acquisitions, enhancing its market reach and service offerings.
Cash flow from operations surged by 92% to $32.6 million. Total revenue for the year reached $259.5 million, a 12.5% increase, while net income per diluted share rose to $1.63 from $1.40. The outlook for fiscal 2025 remains optimistic, with continued growth expected in highly regulated markets and rental services.
Transcat, Inc. (Nasdaq: TRNS) announced the release of its fourth quarter fiscal year 2024 results on May 20, 2024. The company will host a conference call and webcast on May 21, 2024, to discuss financial and operating results, corporate strategy, and outlook.
FAQ
What is the current stock price of Transcat (TRNS)?
What is the market cap of Transcat (TRNS)?
What are the primary business segments of Transcat Inc?
How does Transcat Inc ensure the accuracy and reliability of its calibration services?
Which industries does Transcat Inc serve?
What types of products does the Distribution segment offer?
How do Transcat Inc's services support regulatory compliance?
What distinguishes Transcat Inc's operations in the market?
Can you explain the role of ISO/IEC 17025 accreditation in Transcat’s operations?
How does Transcat Inc integrate its service and distribution segments?
